Strucural Formula (3a498c46 5ad2 416a 875e 18e48b586954 01)
Crestor
Product Images NDC 69189-0752
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 69189-0752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure One (3a498c46 5ad2 416a 875e 18e48b586954 02)
This appears to be a chart of different statin medications (Crestor, Atorvastatin, Simvastatin, Pravastatin) and their doses in milligrams (mg). The chart also shows percent change from "hasel el" (likely a misspelling of "baseline"), possibly indicating the impact of the medication on cholesterol levels or another health metric. However, without more context or a clear format, it is difficult to provide a more specific description or interpretation of the data.*
Figure Two (3a498c46 5ad2 416a 875e 18e48b586954 03)
The text provides information about Cumulative incidence with the help of HR values and Number at risk. However, there is not enough context to determine what the incident is related to.*
Figure Three (3a498c46 5ad2 416a 875e 18e48b586954 04)
The text describes the number of events and related data for a clinical trial. The trial involved two groups: Roswa2omg and Placebo2omg with 8501 and 8901 participants, respectively. The text reports event rates and hazard ratios for primary and secondary endpoints of the trial, including rates of Cardiovascular death, Nonfatal Stroke, Nonfatal MI, and arterial revascularization. The text provides details on how event rate is calculated, and reports p-values for each endpoint comparison.*
Rosuvastatin Calcium 20 mg Tablet (6918907521)
This is a description of a medication called Rosuvastatin Calcium, specifically the 20mg tablet variant. The manufacturer is AstraZeneca and the lot number is HB0184, while the hospital lot number is APF16D13-K. The medication's expiration date is listed as 04/13/2017. The medication is associated with NDC number 6918907521. The remainder of the text is not clear and therefore not available for description.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
